Filtered By:
Source: Neurology
Condition: Hemorrhagic Stroke
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 691 results found since Jan 2013.
Acute Kidney Injury in Acute Stroke. A preliminary study in Hispanic population (P5.041)
Conclusions:The prevalence of AKI after acute stroke in our population is higher than currently reported.Arterial hypertension was observed as a main risk factor. Further analysis with a higher number of patients is needed to confirm this observation and determine its real impact in Hispanic stroke patients.Disclosure: Dr. Olguín-Ramírez has nothing to disclose. Dr. Martínez has nothing to disclose. Dr. Gongora-Rivera has nothing to disclose. Dr. Maya-Quintá has nothing to disclose. Dr. Celis Jasso has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Olguin-Ramirez, L. A., Martinez, H. R., Gongora-Rivera, F., Maya-Quinta, R., Jasso, J. S. C. Tags: Neurocritical Care: Ischemic Injury Source Type: research
Feasibility of Near Infra-Red Spectroscopy in Blood Pressure Management Following Thrombectomy for Acute Large Vessel Occlusion Ischemic Stroke (P5.045)
Conclusions:NIRS monitoring is a feasible method of evaluating patients undergoing thrombectomy for LVO ischemic strokes. This study is continuing to enroll patients to help determine whether NIRS monitoring may help determine better blood pressure targets following thrombectomy.Disclosure: Dr. Saini has nothing to disclose. Dr. Mahapatra has nothing to disclose. Dr. O'Phelan has nothing to disclose. Dr. Kottapally has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Saini, V., Mahapatra, A., OPhelan, K., Kottapally, M. Tags: Neurocritical Care: Ischemic Injury Source Type: research
International Normalized Ratio (INR) Reversal in Oral Anticoagulant-Associated Intracerebral Hemorrhage (P5.049)
Conclusions:Patients with OAC-associated ICH treated with FFP monotherapy are less likely to have a normalized INR at 12h. The use of PCC/rFVIIa shortens time correction to INR to <1.4 but, under the study conditions, this doesn’t improve outcome.Study Supported by: The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study was funded by the National Institute of Neurological Disorders and Stroke (NINDS: U-01-NS069763).Disclosure: Dr. Testai has nothing to disclose. Dr. Mukarram has nothing to disclose. Dr. Castillo has nothing to disclose. Dr. Culpepper has nothing to disclose. Dr. Sekar has received ...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Testai, F., Mukarram, F., Castillo, N., Culpepper, A. L., Sekar, P., Flaherty, M., Ringer, A., Osborne, J., Moomaw, C., Langefeld, C., Sheth, K., Woo, D. Tags: Neurocritical Care: Intracerebral Hemorrhage Source Type: research
Neuroscience Intensive Care Unit Non-Admission Criteria (ICH-NIAC) for Patients with Intracerebral Hemorrhage (P5.052)
Conclusions:We propose that ICH patients (16.5%) that fulfill the following criteria do not have to be admitted to an ICU and can safely be monitored in a step down unit Supratentorial ICHNo respiratory failureICH volume < 20 ccGCS = or > 12No evidence of IVHSBP < 200 mmHgDisclosure: Dr. M. Alkhachroum has nothing to disclose. Dr. Bentho has nothing to disclose. Dr. Chari has nothing to disclose. Dr. Kulhari has nothing to disclose. Dr. Xiong has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Alkhachroum, A. M., Bentho, O., Chari, N., Kulhari, A., Xiong, W. Tags: Neurocritical Care: Intracerebral Hemorrhage Source Type: research
Treatment Patterns and Outcomes of Patients Receiving Direct Oral Anticoagulants or Low Molecular Weight Heparin who Experienced Life-threatening Intracranial Hemorrhage (P5.053)
Conclusions:This study provides a real-world picture of patients receiving FXa inhibitors or LMWH, experiencing life-threatening intracranial bleeds. Despite efforts to restore hemostasis, mortality remained high and substantial healthcare resources were expended. This highlights the need to develop specific strategies for management of ICH in this patient population.Study Supported by: Portola Pharmaceuticals, Inc.Disclosure: Dr. Milling has received personal compensation for activities with CSI Behring, Janssen, BI, and Portola. Dr. Feronti has received research support from Portola. Dr. Clark has received research perso...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Milling, T. J., Feronti, C., Clark, C. L., Fermann, G. J., Song, S. S., Torbati, S. S., Weiss, J., Patel, D., Neuman, W. R. Tags: Neurocritical Care: Intracerebral Hemorrhage Source Type: research
Insular DWI Hyperintensities in Subdural Hematoma: A case series and pathophysiologic review (P5.056)
Conclusions:Proposed mechanisms for SDH-associated insular infarction include venous hypertension and traumatic arterial vasospasm. SDH-associated insular infarction is a marker of greater disease severity. Advanced imaging findings may be an important biomarker of disease severity and may influence complex management decisions. Future prospective studies are necessary to determine the incidence of SDH-associated infarction, putative stroke mechanisms, and resulting patient outcomes.Disclosure: Dr. Sacchetti has nothing to disclose. Dr. Yan has nothing to disclose. Dr. Thompson has nothing to disclose. Dr. Fehnel has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Sacchetti, D., Yan, S., Thompson, B., Fehnel, C. Tags: Neurocritical Care: Intracerebral Hemorrhage Source Type: research
Target Stroke Implementation: Best Practice Strategies Cut Thrombolysis Time to < 30 minutes in a 1,550 Bed Academic Urban County Hospital (P4.280)
Conclusions:Individualized hospital gap analysis identifies targeted interventions to shorten treatment times. DTN and DTG time can be reduced with implementation of simple, low-cost interventions, with persistent effect and no increase in symptomatic intracranial hemorrhage or stroke mimic treatment.Disclosure: Dr. Marulanda-Londoño has nothing to disclose. Dr. Bhatt has nothing to disclose. Dr. Atchaneeyasakul has nothing to disclose. Dr. Asdaghi has nothing to disclose. Dr. Malik has nothing to disclose. Dr. Akram has nothing to disclose. Dr. Zhang has nothing to disclose. Dr. D’Amour has nothing to disclos...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Marulanda-Londono, E., Bhatt, N., Atchaneeyasakul, K., Asdaghi, N., Malik, A., Akram, N., Zhang, T., DAmour, D., Hesse, K., Sacco, R., Romano, J. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research
Analysis of Diagnostic Accuracy, Workflow and Time to Treatment during In-house 'Stroke Codes (P4.282)
Conclusions:Only a minority of ‘stroke codes’ were activated for new ischemic stroke/TIA or large vessel occlusion, while the remaining codes were for altered mental status, seizure, or non-neurologic etiologies. A notable delay occurred between time of code call and imaging. Improved identification of focal symptoms and use of parallel processing for evaluation will be studied in a prospective analysis in effort to improve patient identification and response times.Disclosure: Dr. Manners has nothing to disclose. Dr. Jadhav has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Manners, J., Jadhav, A. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research
Hemorrhagic transformation of ischemic strokes: risk factors and prognostic implications (P4.291)
Conclusions:IV thrombolytic therapy, cardioembolic stroke and prior warfarin use were independent predictors of HT. PH2 was associated with increased risk of poor outcome at around 90 days and mortality at 90 days and 5 years.Disclosure: Dr. Cheung has nothing to disclose. Dr. Chan has nothing to disclose. Dr. Lee has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Cheung, R., Chan, K. H., Lee, R. Tags: In-Hospital Stroke Care Source Type: research
Association of splenic contraction and development of SIRS after acute ischemic stroke. (P4.297)
Conclusions:Based on our initial evaluation, SC detected within 24 hrs of stroke onset is not associated with SIRS suggesting that the relationship between the two may be more complicated in humans. Consistent with prior studies, however, SIRS is associated with worse outcome. Further studies and additional time points are necessary to further clarify the role of the spleen in the development of SIRS in stroke patients.Disclosure: Dr. Zha has nothing to disclose. Dr. Tippinayani has nothing to disclose. Dr. Randhawa has nothing to disclose. Dr. Vahidy has nothing to disclose. Dr. Savitz has received research support from the NIH.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Zha, A., Tippinayani, B., Randhawa, J., Vahidy, F., Savitz, S. Tags: In-Hospital Stroke Care Source Type: research
Analysis of current clinical practice on initiation of anticoagulation in patients with acute ischemic stroke. (P4.298)
Conclusions:Physicians with a subspecialty in vascular neurology, those with more years of experience in practice, and those practicing at academic institutions tended to initiate anticoagulation later.Disclosure: Dr. Olivas has nothing to disclose. Dr. Ajani has nothing to disclose. Dr. Yao has nothing to disclose. Dr. Sangha has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Olivas, E., Ajani, Z., Yao, J., Sangha, N. Tags: In-Hospital Stroke Care Source Type: research
Stroke versus non-stroke neurological complications after cardiac transplant (P4.299)
Conclusions:Neurological complications after CT in our population reach nearly a quarter of patients, similar to or even lower than in previous studies.4.3% of patients developed stroke, ischemic subtype.Pre- and perioperative variables do not differ between both groups, except from ischemic cardiomyopathy as the cause of heart failure being it more frequent in the stroke group.Disclosure: Dr. Vazquez has nothing to disclose. Dr. Thomson has nothing to disclose. Dr. Molina Melendres has nothing to disclose. Dr. Nadile has nothing to disclose. Dr. Gonzalez Toledo has nothing to disclose. Dr. Claverie has nothing to disclose...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Vazquez, G., Thomson, A., Melendres, J. M., Nadile, D., Toledo, M. E. G., Claverie, C. S., Thomson, A., Peradejordi, M., Couto, B., Favaloro, L. E., Favaloro, R., Bertolotti, A., Klein, F. Tags: In-Hospital Stroke Care Source Type: research
Probable rapid eye movement sleep behavior disorder and risk of stroke: a prospective study (P4.302)
Conclusions:Presence of pRBD was associated with a higher risk of developing stroke, including both ischemic and hemorrhagic types. Future studies with clinically confirmed RBD and a longer follow-up would be appropriate to further investigate this association.Study Supported by: The National Institute of Neurological Disorders And Stroke at the National Institutes of Health (NINDS 5R21NS087235-02 to X.G.)Disclosure: Dr. Ma has nothing to disclose. Dr. Pavlova has received research support from Lundbeck and Biomobie Corporation. Dr. Liu has nothing to disclose. Dr. Liu has nothing to disclose. Dr. Huangfu has nothing to di...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Ma, C., Pavlova, M., Liu, Y., Liu, Y., Huangfu, C., Wu, S., Gao, X. Tags: Neuroepidemiology: Cerebrovascular Disease I Source Type: research
Intermediate-term rates of stroke following cardiac procedures: the Nationwide Readmissions Database (P4.305)
Conclusions:Using a large, nationally representative database of inpatient admissions from 2013, we found that 90-day stroke rates are higher after cardiac procedures compared to non-cardiac procedures and non-surgical admissions. However, these rates are likely lower than previously reported.Disclosure: Dr. Stein has nothing to disclose. Dr. Thaler has nothing to disclose. Dr. Liang has nothing to disclose. Dr. Tuhrim has nothing to disclose. Dr. Dhamoon has nothing to disclose. Dr. Dhamoon has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Stein, L., Thaler, A., Liang, J., Tuhrim, S., Dhamoon, A., Dhamoon, M. Tags: Neuroepidemiology: Cerebrovascular Disease I Source Type: research
No association of moon phase with stroke occurrence (P4.309)
Conclusions:In this decade-long nationwide study including a total of 46 million person years of follow-up, we found no association between moon phases and occurrence or in-hospital mortality rates of the three major stroke subtypes (IS, ICH and SAH).Study Supported by: VTR-funding of the hospital district of Southwestern Finland and grant funding of the Finnish Cardiac SocietyDisclosure: Dr. Ruuskanen has received personal compensation for activities with Merck, Biogen, and UCB Pharma. Dr. Siplia has received personal compensation from Orion Corporation, Abbvie, Lundbeck, Merck Serono, and Sanquin. Dr. Rautava has nothing...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Ruuskanen, J., Sipila, J., Rautava, P., Kyto, V. Tags: Neuroepidemiology: Cerebrovascular Disease II Source Type: research
